nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: Implication for post-exposure treatment
|
Papaneri, Amy B. |
|
2013 |
31 |
49 |
p. 5897-5902 6 p. |
artikel |
2 |
Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine
|
Wang, Xuelian |
|
2013 |
31 |
49 |
p. 5806-5813 8 p. |
artikel |
3 |
Can vaccine legacy explain the British pertussis resurgence?
|
Riolo, Maria A. |
|
2013 |
31 |
49 |
p. 5903-5908 6 p. |
artikel |
4 |
Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodies
|
Schiffner, Torben |
|
2013 |
31 |
49 |
p. 5789-5797 9 p. |
artikel |
5 |
Editorial Board
|
|
|
2013 |
31 |
49 |
p. CO2- 1 p. |
artikel |
6 |
HPV vaccination in Hong Kong: Uptake and reasons for non-vaccination amongst Chinese adolescent girls
|
Li, Sophia Ling |
|
2013 |
31 |
49 |
p. 5785-5788 4 p. |
artikel |
7 |
Impact of maternal characteristics on the effect of maternal influenza vaccination on fetal outcomes
|
Adedinsewo, Demilade A. |
|
2013 |
31 |
49 |
p. 5827-5833 7 p. |
artikel |
8 |
Impact of medical education on knowledge and attitudes regarding the human papilloma virus and vaccination: Comparison before and 6 years after the introduction of the vaccines
|
D’Hauwers, K.W.M. |
|
2013 |
31 |
49 |
p. 5843-5847 5 p. |
artikel |
9 |
Levels and functionality of antibodies after pneumococcal conjugate vaccine in schedules with different timing of the booster dose
|
van Westen, Els |
|
2013 |
31 |
49 |
p. 5834-5842 9 p. |
artikel |
10 |
Neurovirulent flavivirus can be attenuated in mice by incorporation of neuron-specific microRNA recognition elements into viral genome
|
Yen, Li-Chen |
|
2013 |
31 |
49 |
p. 5915-5922 8 p. |
artikel |
11 |
Plant heat shock protein 90 as carrier-adjuvant for immunization against a reporter antigen
|
Corigliano, Mariana G. |
|
2013 |
31 |
49 |
p. 5872-5878 7 p. |
artikel |
12 |
Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995–2011
|
Rudnick, Wallis |
|
2013 |
31 |
49 |
p. 5863-5871 9 p. |
artikel |
13 |
Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children
|
Asturias, Edwin J. |
|
2013 |
31 |
49 |
p. 5909-5914 6 p. |
artikel |
14 |
Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: A systematic review
|
Rafferty, Ellen |
|
2013 |
31 |
49 |
p. 5798-5805 8 p. |
artikel |
15 |
Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2–11 years in Malaysia: A randomized, placebo-controlled, Phase III study
|
HSS, Amar-Singh |
|
2013 |
31 |
49 |
p. 5814-5821 8 p. |
artikel |
16 |
Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primates
|
Ault, Alida |
|
2013 |
31 |
49 |
p. 5879-5888 10 p. |
artikel |
17 |
TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses
|
Fox, Christopher B. |
|
2013 |
31 |
49 |
p. 5848-5855 8 p. |
artikel |
18 |
Vaccination coverage levels among children enrolled in the Vaccine Safety Datalink
|
McCarthy, Natalie L. |
|
2013 |
31 |
49 |
p. 5822-5826 5 p. |
artikel |
19 |
Vaccination with proteins involved in tick–pathogen interactions reduces vector infestations and pathogen infection
|
Merino, Octavio |
|
2013 |
31 |
49 |
p. 5889-5896 8 p. |
artikel |
20 |
Validation of the French national health insurance information system as a tool in vaccine safety assessment: Application to febrile convulsions after pediatric measles/mumps/rubella immunization
|
Hanf, Matthieu |
|
2013 |
31 |
49 |
p. 5856-5862 7 p. |
artikel |